Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Leimgruber
Distinct Sets of TCRs Confer Similar Recognition of Tumor Antigen NY-ESO-1157-165 by Interacting With Its Central Met/TRP Residues
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Differential Presentation of a Soluble Exogenous Tumor Antigen, NY-ESO-1, by Distinct Human Dendritic Cell Populations
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Nonclassical Antigen-Processing Pathways Are Required for MHC Class II-Restricted Direct Tumor Recognition by NY-ESO-1-Specific CD4+ T Cells
Cancer immunology research
Cancer Research
Immunology
Key Residues at Third CDR3β Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs
Journal of Immunology
Allergy
Immunology
Regulatory T Cell Depletion Enhances Tumor Specific CD8 T-Cell Responses, Elicited by Tumor Antigen NY-ESO-1b in Hepatocellular Carcinoma Patients, in Vitro
International Journal of Oncology
Cancer Research
Oncology
NY-ESO-1 Antigen-Reactive T Cell Receptors Exhibit Diverse Therapeutic Capability
International Journal of Cancer
Cancer Research
Oncology
A Potential Role for Immunotherapy in Thyroid Cancer by Enhancing NY-ESO-1 Cancer Antigen Expression
Thyroid
Medicine
Endocrinology
Metabolism
Diabetes
Deep Phenotypic Characterization of NY-ESO TCR Engineered T Cells and Tumor in Patients With Advanced Myeloma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
PLoS ONE
Multidisciplinary
Induction of Primary NY-ESO-1 Immunity: CD8+ T Lymphocyte and Antibody Responses in Peptide-Vaccinated Patients With NY-ESO-1+ Cancers
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
